Inotuzumab ozogamicin in individuals with Down syndrome and acute lymphoblastic leukemia
Leukemia, Published online: 03 June 2026; doi:10.1038/s41375-026-02997-0Inotuzumab ozogamicin in individuals with Down syndrome and acute lymphoblastic leukemia
7+
专业文章
3
内容分类
10+
疾病话题
100%
免费阅读
最新文章
查看全部文章 »血液病科普知识、最新研究进展与患者关怀
Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer database analysis
Blood Cancer Journal, Published online: 03 June 2026; doi:10.1038/s41408-026-01533-8Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer
Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis
Blood Cancer Journal, Published online: 02 June 2026; doi:10.1038/s41408-026-01531-wChimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with mult
Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with <i>NRAS</i> mutations to FLT3 inhibitors
Leukemia, Published online: 02 June 2026; doi:10.1038/s41375-026-02982-7Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with NRAS mutations to FLT3 inhibi
FAQ
常见问题
您可能想了解的血液病知识